AB
BVS icon

Amalgamated Bank’s Bioventus BVS Stock Holding History

Amalgamated Bank’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,449
Closed -$11K – 1809
2025
Q4 		$11K Buy
1,449
+150
+12% +$1.08K ﹤0.01% 2361
2025
Q3 		$9K Hold
1,299
– – ﹤0.01% 2504
2025
Q2 		$9K Hold
1,299
– – ﹤0.01% 2467
2025
Q1 		$12K Hold
1,299
– – ﹤0.01% 2273
2024
Q4 		$14K Hold
1,299
– – ﹤0.01% 2265
2024
Q3 		$16K Hold
1,299
– – ﹤0.01% 2214
2024
Q2 		$7K Buy
+1,299
New +$7.13K ﹤0.01% 2596
2023
Q2 		– Sell
-3,134
Closed -$3K – 3047
2023
Q1 		$3K Sell
3,134
-713
-19% -$1.36K ﹤0.01% 2922
2022
Q4 		$10K Hold
3,847
– – ﹤0.01% 2876
2022
Q3 		$27K Hold
3,847
– – ﹤0.01% 2714
2022
Q2 		$26K Sell
3,847
-406
-10% -$4.14K ﹤0.01% 2777
2022
Q1 		$60K Buy
+4,253
New +$56.9K ﹤0.01% 2380

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Amalgamated Bank's BVS Position: Q1 2026 in Review

Amalgamated Bank sold out of Bioventus (BVS) in Q1 2026, closing a stake of 1,449 shares — an estimated $11K sold.

Amalgamated Bank first reported a position in BVS in Q1 2022 and held it in 12 quarters. The position peaked at $60K in Q1 2022. 157 funds tracked by Wall St. Rank hold BVS as of Q1 2026.

  • Amalgamated Bank reported no remaining Bioventus position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,449 Bioventus shares in Q1 2026, an estimated $11K.
  • Amalgamated Bank first reported a position in Bioventus in Q1 2022 and held it in 12 quarters.
  • Amalgamated Bank's Bioventus position peaked at $60K in Q1 2022.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.